Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.

John P. Neoptolemos, Malcolm J. Moore, M. W. Büchler et al.|Journal of Clinical Oncology|2011

Cited by 24